FI-6339 |
NSC-83142 |
DAUNORUBICIN |
RP-13057 |
RP 13057 |
DAUNOXOME |
CERUBIDINE |
VALRUBICIN IMPURITY, DAUNORUBICIN |
FI 6339 |
LEUKAEMOMYCIN C |
(8S-CIS)-8-ACETYL-10-((3-AMINO-2,3,6-TRIDEOXY-ALPHA-L-LYXO-HEXOPYRANNOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-5,12-NAPTHACENEDIONE |
RUBIDOMYCIN |
NDC-0082-4155 |
ACETYLADRIAMYCIN |
(+)-DAUNOMYCIN |
DAUNOMYCIN |
CERUBIDINE® |
DAUNORUBICINA |
DAUNORUBICINUM |
DAUNORUBICINE |
drugbank:00694 |
pubchem.compound:30323 |
rxcui:3109 |
chemidplus:20830-81-3 |
chembl:CHEMBL178 |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antineoplastic agent |
Drug Categories | anthracyclines and related substances |
Drug Categories | anthracycline topoisomerase inhibitor |
Drug Categories | bsep/abcb11 substrates |
Drug Categories | cardiotoxic antineoplastic agents |
Drug Categories | cytochrome p-450 cyp3a inducers |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a4 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 cyp3a5 inducers |
Drug Categories | cytochrome p-450 cyp3a5 inducers (strength unknown) |
Drug Categories | cytochrome p-450 enzyme inducers |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | p-glycoprotein inducers |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | p-glycoprotein substrates |
Drug Categories | p-glycoprotein substrates with narrow therapeutic index |
n/a |
Drug family | Chemotherapy |
Alteration | DNMT3A:. |
inhibitor (inhibitory) |
Trial Name | CPX-351, cytarabine + daunorubicin |
Novel drug target | Established target |
n/a |
Drug family | Chemotherapy |
Alteration | NPM1:. |
n/a |
Drug family | Chemotherapy |
Alteration | MLL__. |
DAUNORUBICIN | DrugBank Drug Name |
20830-81-3 | CAS Number |
Cerubidin | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Categories | anthracycline topoisomerase inhibitor |
Drug Indications | antineoplastic agent |
Drug Class | Small Molecule |
FDA Approval | approved |
C1583 | NCI drug code |
C1583 | NCI drug code |
CHEMBL178 | ChEMBL Drug ID |
D01XWG | TTD Drug ID |